Table of Contents
1、Overview and Background
2、Major Regulatory Updates (20+ Items)
3、Detailed Updates Table
4、Notes and Implementation Instructions
1、Overview and Background
Since 2024, the Thai FDA has implemented multiple updates to cosmetic regulations, including newly prohibited ingredients, revisions to advertising guidelines, strengthened labeling requirements, electronic notification platform enhancements, and updates to GMP/GHP guidelines. This compilation includes more than 20 important regulatory updates to help companies comply, train staff, and manage regulatory obligations.
2、Major Regulatory Updates Overview
- Addition and revision of prohibited ingredients
- Titanium dioxide (TiO₂) nanoparticle usage regulations
- Cosmetic advertising and claims guideline updates
- Strengthened labeling and ingredient disclosure requirements
- Trademark authorization letter requirements
- Product notification and renewal process adjustments
- Classification changes (General vs. Special Control Cosmetics)
- Integration with customs and electronic systems
- Special effect cosmetic approval process updates
- Restrictions on microbeads and sensitizing ingredients
3、Detailed Updates Table
| No. | Notification No. | Release Date | Update Content | Ingredient Changes | Draft/ Consultation | Implementation/ Transition Period |
| 1 | FDA/CTM/ 01 | 2024-11-18 | TiO₂ nanoparticle usage regulations | Maximum concentration and particle size defined | – | Transition period 180 days |
| 2 | FDA/CTM/ 02 | 2024-05-10 | Addition of 56 prohibited ingredients | 56 newly prohibited substances | – | Transition period 180 days |
| 3 | FDA/CTM/ 03 | 2024-07-22 | Proposed addition of 17 prohibited ingredients | 17 newly prohibited substances | Public consultation ongoing | Pending final release |
| 4 | FDA/CTM/ 04 | 2024-06-15 | Cosmetic advertising guideline updates | – | Guidelines issued | Effective immediately |
| 5 | FDA/CTM/ 05 | 2023-12-01 | Product 通知 and labeling requirements | Labels must be in Thai, clear, and accurate | – | Effective immediately |
| 6 | FDA/CTM/ 06 | 2024-02-20 | Trademark authorization letter requirements | Submission of brand authorization required | – | Effective immediately |
| 7 | FDA/CTM/ 07 | 2024-03-05 | Cosmetic classification adjustments | General vs. Special Control Cosmetics | – | Effective immediately |
| 8 | FDA/CTM/ 08 | 2024-04-10 | Product 通知 validity and renewal requirements | Valid for 3 years, renewal possible 6 months prior | ||
| 9 | FDA/CTM/ 09 | 2025-06-01 | Integration with customs and electronic systems | Effective 2025-06-01 | ||
| 10 | FDA/CTM/ 10 | 2024-11-15 | Labeling and claims regulations | Labels in Thai, ingredient list according to international standard | Effective immediately | |
| 11 | FDA/CTM/ 11 | 2024-07-30 | Notification/ license update and fee system | Transition period 180 days | ||
| 12 | FDA/CTM/ 12 | 2024-08-12 | Preservative usage restrictions update | Concentration adjustments for some preservatives | Public consultation ongoing | Transition period 90 days |
| 13 | FDA/CTM/ 13 | 2024-09-05 | 日焼け止め SPF labeling requirements | New SPF labeling requirements | Effective immediately | |
| 14 | FDA/CTM/ 14 | 2024-10-01 | Cosmetic colorant certification update | Some colorants require certification | Transition period 120 days | |
| 15 | FDA/CTM/ 15 | 2024-10-20 | Fragrance allergen usage restrictions | 10 newly restricted fragrance allergens | Transition period 180 days | |
| 16 | FDA/CTM/ 16 | 2024-11-05 | Imported cosmetic review process optimization | Effective immediately | ||
| 17 | FDA/CTM/ 17 | 2024-11-12 | Electronic 通知 platform updates | Added product discontinuation/ relisting function | Effective immediately | |
| 18 | FDA/CTM/ 18 | 2024-12-01 | Cosmetic GHP/GMP guideline updates | Strengthened production hygiene standards | Public consultation ongoing | Transition period 6 months |
| 19 | FDA/CTM/ 19 | 2025-01-10 | Microbead prohibition enhancement | Prohibition of plastic microbeads | Effective immediately | |
| 20 | FDA/CTM/ 20 | 2025-02-05 | Special effect cosmetic approval process | Extra approval required for special effect products | Public consultation ongoing | Transition period 6 months |
4、Notes and Implementation Instructions
- All information is compiled from Thai FDA official announcements and reliable sources.
- Draft/Consultation column indicates regulations still under public consultation.
- Companies should adjust products and internal processes according to transition periods.